Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

1 Stock That’ll Make You Turn Blue in the Face for Owning

Biotech company bluebird bio (BLUE) received FDA approval for ZYNTEGLO last month, which seems to have boosted its stock price. However, given its bleak profitability and stretched valuations, the stock might be best avoided. Read on….

California and New York aim to curb diet pill sales to minors

California and New York are on the cusp of going further than the FDA in restricting the sale of non-prescription diet pills to minors as pediatricians and public health advocates try to protect kids from extreme weight-loss gimmicks online.

Tribune News Service

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy individuals 10 through 25 years of age. The trial met all primary and secondary endpoints. Pfizer shares traded in a range of $45.7…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Experts debunk bizarre celebrity health trends from 'Vampire Facial' to drinking wee

Health professionals hit out at some of the wacky ways stars to stay in top shape - such as Kim Kardashian's face smeared and injected with her own blood.

Bipartisan Lawmakers Call Out FDA's 'Inadequate' Response To Hemp And CBD Regulations

Bipartisan House members sent a letter to the FDA commissioner to complain about the agency's “completely insufficient response” to their bill, which called for hemp-derived CBD to be permitted and regulated as a food additive.

US warns monkeypox could mutate to resist antiviral drug

U.S. health officials are warning doctors against overusing the lone drug available to treat monkeypox

The Independent UK

Outrageous celebrity health trends debunked - from Kim K's 'Vampire Facial' to vaginal sunbathing

Some of the more wild and wacky methods our stars use to stay in tip-top shape are not really such a great idea, warn experts

inkl

Read news from The Economist, FT, and more,
with one subscription

This 1 Stock Pays You Just for Owning It

This 1 Stock Pays You Just for Owning It

Leading pharmaceutical company Pfizer (PFE) did exceptionally well during the pandemic thanks to the high demand for its COVID-19 vaccine, and it still has enough growth prospects. The company’s focus on strengthening its pipeline via business acquisitions, product development, and approvals is expected to deliver impressive growth in the upcoming…

Experts question the role of white mulberry in the death of congressman’s wife

SACRAMENTO, Calif. — Scientists, doctors and pathologists are questioning the Sacramento County coroner’s conclusion that Lori McClintock’s death was related to white mulberry, a plant that has been used as an herbal remedy for centuries — and one that the coroner’s botanical consultant called “not toxic” in a letter to…

Tribune News Service

MAPS Gets A New Partner To Study MDMA Therapy In Patients With PTSD

MAPS Gets A New Partner To Study MDMA Therapy In Patients With PTSD

In recent months, the psychedelics space has been ground for increasing collaborations. In some cases it was to advance scientific studies.

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

FDA issues urgent recall on Medtronic surgical tubes

The U.S. Food and Drug Administration has issued a Class I recall, the agency's most serious category, for certain tracheal tubes made by Medtronic.

Tribune News Service

New ALS drug funded by Ice Bucket Challenge already in use in South Florida trials

While the country awaits federal approval of a new ALS drug, people in South Florida with the disease already are using it.

Tribune News Service

Is the new omicron vaccine worth it?

Is the new omicron vaccine worth it?

The omicron-specific booster vaccine hit the market — some wonder if it's worth getting

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Commentary: Did the US jump the gun with the new omicron-targeted vaccines?

Last month, the FDA authorized omicron-specific vaccines, accompanied by breathless science-by-press release and a media blitz. Just days after the FDA’s move, the Centers for Disease Control and Prevention followed, recommending updated boosters for anyone age 12 and up who had received at least two doses of the original COVID-19…

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.

Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary

Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), the study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Akero Therapeutics shares…

5 “Strong Buy” Health Care Stocks to Buy This Week

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

Get all your
news in one place.

100's of premium titles.
One news app.

Affordability questions linger around over-the-counter birth control

"There is no single magic bullet to solving all problems with access and affordability issues."

3 Health Care Stock Under $50 You Can Buy Today

The healthcare industry is anticipated to grow significantly in the coming years, thanks to strong demand amid rising chronic diseases, technological advancements, and rising healthcare spending. Therefore, we think fundamentally sound healthcare companies Pfizer (PFE), GSK Plc (GSK), and Teva Pharmaceutical (TEVA), which are currently trading under $50, could be…

ATE.TO: Plans on Track for Acute Pain Program for Otenaproxesul…

By David Bautz, PhD OTC:ATBPF | TSX:ATE.TO READ THE FULL ATE.TO RESEARCH REPORT

Covid-19 boosters: Immunologists answer 5 key questions about the new shots

What is different about the updated booster shots? Two scientists offer their expertise to answer five questions about the shots.

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Juul just lost a big battle

The e-cigarette company was being investigated by more than 30 states for allegedly marketing its products to youth

3 Dividend Stocks You Can Buy and Hold for Years to Come

The stock market has witnessed significant volatility on worries over a slowing economy amid high inflation and the Fed’s hawkish stance to tame it. As these factors are expected to keep the market under pressure in the near term, it could be wise to invest in fundamentally strong dividend-paying stocks…

1 … 170 171 172 173

People

Gwyneth Paltrow

Mangeet Kaur BounsMangeet

Shailene Woodley

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Centers for Disease Control and Prevention

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

360,288 stories

Sacramento County

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play